Progress 10/01/13 to 07/31/14
Outputs Target Audience:A progress report was submitted to the funding agency. Changes/Problems:A progress report was submitted to the funding agency. What opportunities for training and professional development has the project provided?A progress report was submitted to the funding agency. How have the results been disseminated to communities of interest?A progress report was submitted to the funding agency. What do you plan to do during the next reporting period to accomplish the goals?A progress report was submitted to the funding agency.
Impacts What was accomplished under these goals?
A progress report was submitted to the funding agency.
Publications
|
Progress 09/10/04 to 07/31/14
Outputs Target Audience:
Nothing Reported
Changes/Problems:
Nothing Reported
What opportunities for training and professional development has the project provided?
Nothing Reported
How have the results been disseminated to communities of interest?
Nothing Reported
What do you plan to do during the next reporting period to accomplish the goals?
Nothing Reported
Impacts What was accomplished under these goals?
Final Report Submitted to the funding Agency
Publications
|
Progress 10/01/12 to 09/30/13
Outputs Target Audience:
Nothing Reported
Changes/Problems:
Nothing Reported
What opportunities for training and professional development has the project provided?
Nothing Reported
How have the results been disseminated to communities of interest?
Nothing Reported
What do you plan to do during the next reporting period to accomplish the goals?
Nothing Reported
Impacts What was accomplished under these goals?
This proposal was submitted to a different sponsor and progress reports were submitted to the appropriate agency.
Publications
|
Progress 10/01/11 to 09/30/12
Outputs Target Audience:
Nothing Reported
Changes/Problems:
Nothing Reported
What opportunities for training and professional development has the project provided?
Nothing Reported
How have the results been disseminated to communities of interest?
Nothing Reported
What do you plan to do during the next reporting period to accomplish the goals?
Nothing Reported
Impacts What was accomplished under these goals?
This proposal was submitted to a different sponsor and progress reports were submitted to the appropriate agency.
Publications
|
Progress 10/01/10 to 09/30/11
Outputs Target Audience:
Nothing Reported
Changes/Problems:
Nothing Reported
What opportunities for training and professional development has the project provided?
Nothing Reported
How have the results been disseminated to communities of interest?
Nothing Reported
What do you plan to do during the next reporting period to accomplish the goals?
Nothing Reported
Impacts What was accomplished under these goals?
This project was submitted to a different sponsor and progress reports were submitted to the appropriate agency.
Publications
|
Progress 01/01/10 to 09/30/10
Outputs Target Audience:
Nothing Reported
Changes/Problems:
Nothing Reported
What opportunities for training and professional development has the project provided?
Nothing Reported
How have the results been disseminated to communities of interest?
Nothing Reported
What do you plan to do during the next reporting period to accomplish the goals?
Nothing Reported
Impacts What was accomplished under these goals?
This proposal was submitted by a different sponsor. Progress Reports were submitted to the appropriate agency.
Publications
|
Progress 01/01/09 to 12/31/09
Outputs OUTPUTS: We are continuing to investigate oxidant injury and repair of airway epithelial cells. We were unsuccessful in generating a transgenic thioredoxin mouse. We have investigated the role of neuropeptides, substance P and CGRP, in airway epithelial injury and repair after ozone exposure. PARTICIPANTS: Karen Oslund, Reen Wu, Dallas Hyde, Ed Schelegle. Training for Karen Oslund: Course on Stereology University of Seattle Sept. 2009. Workshop on chromatin immunoprecipitation. UC Davis Oct. 2009 TARGET AUDIENCES: Not relevant to this project. PROJECT MODIFICATIONS: Nothing significant to report during this reporting period.
Impacts We have shown that the neuropeptides, substance P and CGRP, contribute to airway epithelial cell injury and repair. Rats that were treated with a receptor antagonist to either NK-1R, the substance P receptor, or a CGRP receptor antagonist, demonstrated attenuated airway epithelial injury and repair after ozone exposure. Additionally, injured airway epithelial cells demonstrated cytoplasmic localization of Nur77, a mediator of non-apoptotic programmed cell death, suggesting this cell death pathway maybe important in ozone induced injury.
Publications
- Oslund KL, Hyde DM, Putney LF, Alfaro MF, Walby WF, Tyler NK, Schelegle ES. Activation of Calcitonin Gene-Related Peptide Receptor during Ozone Inhalation Contributes to Epithelial Injury and Repair. 2009. Journal of Toxicological Pathology. 37(6):805-813.
|
Progress 01/01/08 to 12/31/08
Outputs OUTPUTS: The continuing development of this useful transgenic mouse and characterization of the line will be a priority for next year. This work is directly related to specific aim #3 in which will use these mice to study neutrophil recruitment and co-localization in the airway epithelium after ozone exposure. These results are significant because we are advancing towards our ultimate goal of generating a transgenic mouse overexpressing thioreodixn exclusively in the airway epithelium. When created, this mouse will be a valuable to tool to further understand the role of thioredoxin not only in these studies but in diverse models of inflammation and injury involving the lungs. we have completed a study investigating the role of thioredoxin in cytotoxicity after smoke injury. This work has been submitted for publication to the Journal of American Physiology: Lung Cell and Molecular Biology. PARTICIPANTS: Karen Oslund PI Reen Wu Mentor Dallas Hyde Advisor TARGET AUDIENCES: No Target Audiences information reported. PROJECT MODIFICATIONS: No Project Modifications information reported.
Impacts Our preliminary results from the in vitro neutrophil experiments found that neutrophils remove significantly more thioredoxin over-expressing cells compared to wildtypes. Additionally, this result was not affected by neutrophil number i.e. more neutrophils did not result in significantly different results. We are in the process of analyzing additional data from this experiment. These results are significant because it expands the findings from our earlier work that neutrophils preferentially co-localize with airway epithelial cells over-expressing thioredoxin. This work continues to demonstrate the role of thioredoxin in targeting and removing airway epithelial cells expressing thioredoxin. Additionally we have found that thioredoxin is important in protecting subconfluent cultures of airway epithelial cells from smoke induced injury. Low density cultures of several airway epithelial cell types (primary human, monkey and a cell line HBE1) are more susceptible to cytotoxicity induced by cigarette smoke compared to confluent cultures. However, if we over-express thioredoxin in subconfluent cultures, the cells are protected from smoke injury. We feel that this is an important model for airway epithelial cells undergoing regeneration after an injury when they are in a subconfluent state. We hope to investigate this phenomenon in vivo.
Publications
- No publications reported this period
|
Progress 01/01/07 to 12/31/07
Outputs OUTPUTS: Specific Aims: The specific aims for this project have not changed. This past year a major focus of this project has been breeding and development of a double transgenic mouse. We have successfully isolated and performed a pronuclear injection of a established a line of mice containing a tetracycline inducible plasmid with wildtype thioredoxin. Additionally, these mice have been successfully crossed with CCSP tetracycline regulator mice provided by a researcher in our laboratory. We are in the process of administering doxycycline (a tetracycline derivative in the drinking water of some of the double transgenic mice to determine if thioredoxin will be selectively overexpressed in the airway epithelium. The continuing development of this useful transgenic mouse and characterization of the line will be a priority for next year. This work is directly related to specific aim #3 in which will use these mice to study neutrophil recruitment and co-localization in the airway
epithelium after ozone exposure. These results are significant because we are advancing towards our ultimate goal of generating a transgenic mouse overexpressing thioreodixn exclusively in the airway epithelium. When created, this mouse will be a valuable to tool to further understand the role of thioredoxin not only in these studies but in diverse models of inflammation and injury involving the lungs. Secondly, we continuing to investigate neutrophil mediated removal of thioredoxin overexpressing airway epithelial cells in vitro related to specific aim #2. We are in the process of completing a study investigating whether quiescent and activated neutrophils preferentially remove airway epithelial cells over-expressing thioredoxin. Finally, we have completed a study investigating the role of thioredoxin in cytotoxicity after smoke injury. This work has been submitted for publication to the Journal of American Physiology: Lung Cell and Molecular Biology.
PARTICIPANTS: Karen Oslund PI Reen Wu Mentor Dallas Hyde Advisor
Impacts Our preliminary results from the in vitro neutrophil experiments found that neutrophils remove significantly more thioredoxin over-expressing cells compared to wildtypes. Additionally, this result was not affected by neutrophil number i.e. more neutrophils did not result in significantly different results. We are in the process of analyzing additional data from this experiment. These results are significant because it expands the findings from our earlier work that neutrophils preferentially co-localize with airway epithelial cells over-expressing thioredoxin. This work continues to demonstrate the role of thioredoxin in targeting and removing airway epithelial cells expressing thioredoxin. Additionally we have found that thioredoxin is important in protecting subconfluent cultures of airway epithelial cells from smoke induced injury. Low density cultures of several airway epithelial cell types (primary human, monkey and a cell line HBE1) are more susceptible to
cytotoxicity induced by cigarette smoke compared to confluent cultures. However, if we over-express thioredoxin in subconfluent cultures, the cells are protected from smoke injury. We feel that this is an important model for airway epithelial cells undergoing regeneration after an injury when they are in a subconfluent state. We hope to investigate this phenomenon in vivo.
Publications
- No publications reported this period
|
|